Cargando…
Single low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects
BACKGROUND: Recombinant human interleukin 12 (rHuIL-12) regulates hematopoiesis and cell-mediated immunity. Based on these hematopoietic and immunomodulatory activities, a recombinant human IL-12 (rHuIL-12) is now under development to address the unmet need for a medical countermeasure against the h...
Autores principales: | Gokhale, Mamata S, Vainstein, Vladimir, Tom, Jamie, Thomas, Simmy, Lawrence, Chris E, Gluzman-Poltorak, Zoya, Siebers, Nicholas, Basile, Lena A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991894/ https://www.ncbi.nlm.nih.gov/pubmed/24725395 http://dx.doi.org/10.1186/2162-3619-3-11 |
Ejemplares similares
-
What's new in IL-12? Combination!
por: Lawrence, Chris E, et al.
Publicado: (2015) -
Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation
por: Gluzman-Poltorak, Zoya, et al.
Publicado: (2014) -
Gene expression changes in male and female rhesus macaque 60 days after irradiation
por: Majewski, Matthäus, et al.
Publicado: (2021) -
Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice
por: Basile, Lena A, et al.
Publicado: (2008) -
Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression
por: Trinh, Alice T, et al.
Publicado: (2009)